IGF-1 regulates migration and angiogenesis of human endothelial cells

Endocr J. 1999 Mar:46 Suppl:S59-62. doi: 10.1507/endocrj.46.suppl_s59.

Abstract

Recent studies revealed favorable para- and/or autocrine effects of IGF-1 in the pathogenesis of diabetic complications. On the other hand, hyperglycemia is a risk factor for the development of diabetic vascular complications. In this study we examined the effects of high glucose and/or IGF-1 on cell migration and angiogenesis (tubular formation) by using human endothelial cells (EC) in vitro. First we examined cell migration by the two-chamber method. Chronic treatment with a high concentration of D-glucose strongly stimulated the cell migration, which was mimicked by PMA, a protein kinase C (PKC) agonist. The cell migration was also induced by IGF-1. The glucose-induced cell migration was blocked by PKC inhibitor, H7. IGF-1-induced cell migration was not blocked by PD98059, MAPK/ERK kinase (MEK) inhibitor or wortmannin, a phosphatidylinositol (PI) 3-kinase inhibitor. Next we examined the effects of high glucose and/or IGF-1 on the tubular formation of EC. The tubular formation was induced only when the cells were exposed to a combination of high glucose and IGF-1. The tubular formation was blocked by MEK inhibitor and PI 3-kinase inhibitor but not by PKC inhibitor. These results indicate that hyperglycemia and IGF-1, respectively, stimulate the EC migration, and tubular formation is induced by a combination of IGF-1 and hyperglycemia.

MeSH terms

  • Androstadienes / pharmacology
  • Cell Movement / drug effects*
  • Cell Movement / physiology
  • Cells, Cultured
  • Chromones / pharmacology
  • Endothelium, Vascular / cytology*
  • Endothelium, Vascular / drug effects
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Glucose / adverse effects
  • Glucose / pharmacology
  • Humans
  • Insulin-Like Growth Factor I / pharmacology*
  • Morpholines / pharmacology
  • Neovascularization, Physiologic / drug effects*
  • Neovascularization, Physiologic / physiology
  • Tetradecanoylphorbol Acetate / pharmacology
  • Wortmannin

Substances

  • Androstadienes
  • Chromones
  • Enzyme Inhibitors
  • Flavonoids
  • Morpholines
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Insulin-Like Growth Factor I
  • Glucose
  • Tetradecanoylphorbol Acetate
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Wortmannin